Publicaciones en las que colabora con DAVID SEVILLANO FERNÁNDEZ (38)

2024

  1. Strengthening the relationship between intractable plantar keratosis and human papillomavirus

    Journal of Medical Virology, Vol. 96, Núm. 2

2023

  1. Do face masks increase the rate of the Staphylococcus aureus nasal carriers?

    Revista Espanola de Quimioterapia

  2. Fungal bioaerosol as an occupational hazard in the podiatrist’s workplace

    International Journal of Environmental Health Research, Vol. 33, Núm. 2, pp. 180-191

2022

  1. Age-based inter-subject variability in platelet and white blood cell concentrations of platelet-rich plasma prepared using a new application to blood separation system

    International Wound Journal, Vol. 19, Núm. 2, pp. 362-369

  2. Influence of Sexual Dimorphism, Aging, and Differential Cell Capture Efficiency of Blood Separation Systems on the Quality of Platelet-Rich Plasma

    Journal of Clinical Medicine, Vol. 11, Núm. 6

2021

  1. Commercial blood cell separation systems versus tube centrifugation methods for the preparation of platelet-rich plasma: A preliminary cross-sectional study

    Revista da Associacao Medica Brasileira, Vol. 67, Núm. 4, pp. 536-541

  2. Comparing rubbing and scrubbing surgical hand antisepsis with propan-1-ol 60% in accordance with European regulation UNE-EN 12791:2016+A1:2018

    Infection Control and Hospital Epidemiology, Vol. 42, Núm. 11, pp. 1382-1384

2020

  1. Estudiando la microbiota a través de la prevalencia de portadores nasales de Staphylococcus aureus en los estudiantes de Microbiología del Grado de Podología

    EJPOD: European Journal of Podiatry = Revista europea de podología, Vol. 6, Núm. 2, pp. 41-49

2019

  1. Bactericidal ZnO glass-filled thermoplastic polyurethane and polydimethyl siloxane composites to inhibit biofilm-associated infections

    Scientific Reports, Vol. 9, Núm. 1

  2. Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains

    Journal of Global Antimicrobial Resistance, Vol. 19, pp. 241-251

2018

  1. Impact of the biotic and abiotic components of low mineralized natural mineral waters on the growth of pathogenic bacteria of human origin: A key to self-control of spa water quality

    Journal of Hydrology, Vol. 566, pp. 227-234

2013

  1. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 10, pp. 2291-2295

  2. Protection of Enterococcus faecalis in mixed cultures with carbapenemase-producing Escherichia coli and Bacteroide fragilis: effect of the bacterial load.

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26, Núm. 3, pp. 220-225

2012

  1. Efecto de la unión a proteínas en la actividad de voriconazol solo o combinado con anidulafungina frente aspergillus spp. Mediante curves de letalidad

    Revista Espanola de Quimioterapia, Vol. 25, Núm. 1, pp. 47-55

2011

  1. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24 h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate- resistant Staphylococcus aureus

    International Journal of Antimicrobial Agents, Vol. 37, Núm. 4, pp. 332-338

  2. Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 6, pp. 2788-2794

2010

  1. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2 μg/mL

    International Journal of Antimicrobial Agents, Vol. 35, Núm. 2, pp. 131-137

  2. Cefditoren versus ceftazidime in inducersubstrate combinations for the evaluation of AmpC production in a disc approximation test

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 2, pp. 72-75

  3. Enhanced in vivo activity of cefditoren in preimmunized mice against penicillin-resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a sepsis model

    PLoS ONE, Vol. 5, Núm. 8

  4. Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria

    International Journal of Antimicrobial Agents, Vol. 36, Núm. 2, pp. 137-144